In livestock and poultry production, inflammation reduces profitability and product quality and endangers the health of the animals. Inflammation can occur in intensive, modern animal production systems. Controlling inflammation increases the likelihood of a positive ROI regarding feed conversion. As a result, commonly used antimicrobials in feed are now a proposed mode of action (MOA) to reduce instances of inflammation occurrence.
The digestive tract of a healthy chick is considered free from microorganisms at hatch. Afterwards, a microbial colonization evolves very quickly. At around 40 days in age, the microbiota becomes fully developed in birds, and the bacteria can be categorized as commensal or pathogenic. The bacterial population within broilers is very diverse comprised of over 900 species.
A healthy gastrointestinal (GI) tract can help poultry achieve optimal production of meat or eggs. The GI tract for chicken has two essential functions: digestion/absorption and immunity. The intestinal mucosa provides an efficient barrier between unfriendly luminal content and the host's internal tissues. A cohesive alliance between the mucus layer, epithelial cells, microbiota and immune cells in the intestine is critical for the intestinal barrier functions.
Minimizing the susceptibility to disease challenges early on in an animal's life can have an effect on their ability to gain weight faster, convert feed more efficiently and overall animal health. Aleta™, a source of 1,3-beta glucans, is an ingredient that may enhance host protective immunity (mucosal and systemic immunity) by improving the effector functions of immune cells.